248 related articles for article (PubMed ID: 15182226)
41. Prion protein misfolding, strains, and neurotoxicity: an update from studies on Mammalian prions.
Poggiolini I; Saverioni D; Parchi P
Int J Cell Biol; 2013; 2013():910314. PubMed ID: 24454379
[TBL] [Abstract][Full Text] [Related]
42. PrP P102L and Nearby Lysine Mutations Promote Spontaneous
Kraus A; Raymond GJ; Race B; Campbell KJ; Hughson AG; Anson KJ; Raymond LD; Caughey B
J Virol; 2017 Nov; 91(21):. PubMed ID: 28835493
[TBL] [Abstract][Full Text] [Related]
43. Degradation of the disease-associated prion protein by a serine protease from lichens.
Johnson CJ; Bennett JP; Biro SM; Duque-Velasquez JC; Rodriguez CM; Bessen RA; Rocke TE
PLoS One; 2011 May; 6(5):e19836. PubMed ID: 21589935
[TBL] [Abstract][Full Text] [Related]
44. beta-sheet constitution of prion proteins.
Ji HF; Zhang HY
Trends Biochem Sci; 2010 Mar; 35(3):129-34. PubMed ID: 20060302
[TBL] [Abstract][Full Text] [Related]
45. Unraveling the details of prion (con)formation(s): recent advances by mass spectrometry.
Principe S; Maras B; Schininà ME; Pocchiari M; Cardone F
Curr Opin Drug Discov Devel; 2008 Sep; 11(5):697-707. PubMed ID: 18729021
[TBL] [Abstract][Full Text] [Related]
46. Nucleic acid and prion protein interaction produces spherical amyloids which can function in vivo as coats of spongiform encephalopathy agent.
Nandi PK; Nicole JC
J Mol Biol; 2004 Nov; 344(3):827-37. PubMed ID: 15533448
[TBL] [Abstract][Full Text] [Related]
47. Sulfated glycans and elevated temperature stimulate PrP(Sc)-dependent cell-free formation of protease-resistant prion protein.
Wong C; Xiong LW; Horiuchi M; Raymond L; Wehrly K; Chesebro B; Caughey B
EMBO J; 2001 Feb; 20(3):377-86. PubMed ID: 11157745
[TBL] [Abstract][Full Text] [Related]
48. Prion diseases and emerging prion diseases.
Yokoyama T; Mohri S
Curr Med Chem; 2008; 15(9):912-6. PubMed ID: 18473798
[TBL] [Abstract][Full Text] [Related]
49. Antiprion properties of prion protein-derived cell-penetrating peptides.
Löfgren K; Wahlström A; Lundberg P; Langel U; Gräslund A; Bedecs K
FASEB J; 2008 Jul; 22(7):2177-84. PubMed ID: 18296502
[TBL] [Abstract][Full Text] [Related]
50. Insights into prion strains and neurotoxicity.
Aguzzi A; Heikenwalder M; Polymenidou M
Nat Rev Mol Cell Biol; 2007 Jul; 8(7):552-61. PubMed ID: 17585315
[TBL] [Abstract][Full Text] [Related]
51. Prion diseases: from molecular biology to intervention strategies.
Nunziante M; Gilch S; Schätzl HM
Chembiochem; 2003 Dec; 4(12):1268-84. PubMed ID: 14661267
[TBL] [Abstract][Full Text] [Related]
52. Fukuoka-1 strain of transmissible spongiform encephalopathy agent infects murine bone marrow-derived cells with features of mesenchymal stem cells.
Cervenakova L; Akimov S; Vasilyeva I; Yakovleva O; McKenzie C; Cervenak J; Piccardo P; Asher DM
Transfusion; 2011 Aug; 51(8):1755-68. PubMed ID: 21303371
[TBL] [Abstract][Full Text] [Related]
53. [Biology of non-conventional transmissible agents or prions].
Dormont D
Rev Neurol (Paris); 1998 Feb; 154(2):142-51. PubMed ID: 9773035
[TBL] [Abstract][Full Text] [Related]
54. Utility of RNAi-mediated prnp gene silencing in neuroblastoma cells permanently infected by prions: potentials and limitations.
Kim Y; Han B; Titlow W; Mays CE; Kwon M; Ryou C
Antiviral Res; 2009 Nov; 84(2):185-93. PubMed ID: 19748523
[TBL] [Abstract][Full Text] [Related]
55. Clearance of prions during plasma protein manufacture.
Burdick MD; Pifat DY; Petteway SR; Cai K
Transfus Med Rev; 2006 Jan; 20(1):57-62. PubMed ID: 16373188
[TBL] [Abstract][Full Text] [Related]
56. A 25 nm virion is the likely cause of transmissible spongiform encephalopathies.
Manuelidis L
J Cell Biochem; 2007 Mar; 100(4):897-915. PubMed ID: 17044041
[TBL] [Abstract][Full Text] [Related]
57. Mechanisms of prion-induced neurodegeneration.
Saá P; Harris DA; Cervenakova L
Expert Rev Mol Med; 2016 Apr; 18():e5. PubMed ID: 27055367
[TBL] [Abstract][Full Text] [Related]
58. Sc237 hamster PrPSc and Sc237-derived mouse PrPSc generated by interspecies in vitro amplification exhibit distinct pathological and biochemical properties in tga20 transgenic mice.
Yoshioka M; Imamura M; Okada H; Shimozaki N; Murayama Y; Yokoyama T; Mohri S
Microbiol Immunol; 2011 May; 55(5):331-40. PubMed ID: 21362027
[TBL] [Abstract][Full Text] [Related]
59. CNS delivery of vectored prion-specific single-chain antibodies delays disease onset.
Wuertzer CA; Sullivan MA; Qiu X; Federoff HJ
Mol Ther; 2008 Mar; 16(3):481-6. PubMed ID: 18180775
[TBL] [Abstract][Full Text] [Related]
60. Species barrier in prion diseases: a kinetic interpretation based on the conformational adaptation of the prion protein.
Kellershohn N; Laurent M
Biochem J; 1998 Sep; 334 ( Pt 3)(Pt 3):539-45. PubMed ID: 9729459
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
